Alzheimer’s disease tagged posts

Light Stimulation of brain cells can Recover Memories in mice with Alzheimer’s disease-like memory loss

Engram cell in AD mouse -- This image depicts a single memory engram cell (green) in the hippocampal dentate gyrus (DG) region of a mouse model of early Alzheimer's disease. To optically manipulate specific connections to these engram cells, a blue light-sensitive protein oChIEF was expressed in an upstream brain region, i.e., medial entorhinal cortical inputs (red) to the DG. The majority of DG granule cells were not active during engram labeling (blue, non-engram cells). Credit: Image courtesy of RIKEN

Engram cell in AD mouse — This image depicts a single memory engram cell (green) in the hippocampal dentate gyrus (DG) region of a mouse model of early Alzheimer’s disease. To optically manipulate specific connections to these engram cells, a blue light-sensitive protein oChIEF was expressed in an upstream brain region, i.e., medial entorhinal cortical inputs (red) to the DG. The majority of DG granule cells were not active during engram labeling (blue, non-engram cells). Credit: Image courtesy of RIKEN

The rescue of memories, which changed both the structure of neurons as well as the behavior of mice, was achieved using optogenetics, a method for manipulating genetically tagged cells with precise bursts of light...

Read More

Researchers highlight Brain Region as ‘Ground 0’ of Alzheimer’s disease

brain stem (2nd version)

Blue indicates the location of the tiny locus coeruleus within the brainstem. (Photo/Shutterstock.com)

The locus coeruleus region of the brain is essential for maintaining cognitive function as a person ages, but is vulnerable to toxins and infection. The locus coeruleus is a small, bluish part of the brainstem that releases norepinephrine, the neurotransmitter responsible for regulating heart rate, attention, memory, and cognition. Its cells, or neurons, send branch-like axons throughout much of the brain and help regulate blood vessel activity. Its high interconnectedness may make it more susceptible to the effects of toxins and infections compared to other brain regions.

Prof...

Read More

Researchers identify ‘Neurostatin’ that may Reduce the Risk of Alzheimer’s disease

Schematic illustration of the drug discovery strategy described in this work. The strategy consists of four steps: (1) A fragment-based approach that allows the identification of small molecules that interact with the aggregation-prone system, here Aβ42, including FDA-approved molecules for drug repurposing. (2) An in vitro kinetic analysis that identifies the specific molecular steps in the Aβ42 aggregation mechanism responsible for the generation of toxic species. (3) A further kinetic analysis to determine the mechanism of inhibition associated with the molecules identified in step 1. (4) An evaluation of the effects of these molecules on the formation of toxic species in vivo. In particular, the inhibition of primary nucleation is predicted to delay the aggregation without affecting the total number of oligomers generated by the aggregation process, whereas inhibiting elongation or secondary nucleation is predicted either to increase or to decrease the number of toxic oligomers, respectively (see text).

Schematic illustration of the drug discovery strategy described in this work. The strategy consists of four steps: (1) A fragment-based approach that allows the identification of small molecules that interact with the aggregation-prone system, here Aβ42, including FDA-approved molecules for drug repurposing. (2) An in vitro kinetic analysis that identifies the specific molecular steps in the Aβ42 aggregation mechanism responsible for the generation of toxic species. (3) A further kinetic analysis to determine the mechanism of inhibition associated with the molecules identified in step 1. (4) An evaluation of the effects of these molecules on the formation of toxic species in vivo...

Read More

Lipid-based diets effectively Combat Alzheimer’s disease in mouse model

Researchers have devised several lipid-based diets aimed at slowing down progression and relieving symptoms of Alzheimer's disease. Credit: Janickova et al, Bentham Science Publishers

Researchers have devised several lipid-based diets aimed at slowing down progression and relieving symptoms of Alzheimer’s disease. Credit: Janickova et al, Bentham Science Publishers

Numerous epidemiological studies have revealed profitable effects of dietary intake of especially fish oil on cognitive decline during aging and dementia. One of the invariable pathologies in AD is degeneration of cholinergic synapses in brain cortex and hippocampus. Current pharmacological interventions are limited to a few drugs that alleviate symptoms but do not slow down the underlying disease processes eg inhibitors of cholinesterases, enzymes that degrade the neurotransmitter acetylcholine, or memantine, a modulator of glutamate neurotransmission.

Within the EU-funded project LipiDiDiet (FP7-211696, the...

Read More